<qa>  What is the name of the trial that is at its Phase II stage?This trial is designed to investigate the safety, dosing schedule, and efficacy of the combination treatment of Panobinostat a histone deacetylase inhibitor and hormone therapy for recurrent prostate cancer. This trial is at its Phase II stage. As of July 23, 2013 Arm B was closed to accrual, all the remaining slots in accrual will be allocated to Arm A. 